71 – 80 of 118
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Cytostatic drug treatment causes seeding of gene promoter methylation.
(
- Contribution to journal › Article
-
Mark
Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast - Results from the Swedish randomised trial.
(
- Contribution to journal › Article
-
Mark
Identification of low-risk tumours in histological high-grade soft tissue sarcomas
(
- Contribution to journal › Article
- 2006
-
Mark
Reduced mortality for women with mammography-detected breast cancer in east Denmark and south Sweden
(
- Contribution to journal › Article
-
Mark
Clinical applications of newer radionuclide therapies
(
- Contribution to journal › Article
-
Mark
Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: An EORTC phase III study (10863)
(
- Contribution to journal › Article
-
Mark
Autoimmune diseases, asthma and risk of haematological malignancies: A nationwide case-control study in Sweden
(
- Contribution to journal › Article
-
Mark
Gene expression profilers and conventional clinical markers to predict distant recurrences for premenopausal breast cancer patients after adjuvant chemotherapy.
(
- Contribution to journal › Article
- 2005
-
Mark
European multi-centre case-control study on risk factors for rare cancers of unknown aetiology
(
- Contribution to journal › Article
-
Mark
Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up.
(
- Contribution to journal › Article